The country is trying to supplant the United States as the world leader in this sector.
The need is growing for life-saving treatments.
The president’s tariffs on imports, especially steel and aluminum, could increase input production costs, making products more expensive.
It’s critical to understand the characteristics of this country’s market to determine the most effective steps.
Although the market is expected to experience strong growth, the quality of care is inconsistent.
Economic development in China has created a burgeoning middle class that demands higher standards of living.
The President’s actions (or distractions) may be detrimental to Western medical device companies.
As standalone software becomes increasingly sophisticated, a number of regulatory bodies have begun to draft separate guidelines to ensure quality control, expedite product approval, and improve patient access to new technologies.
Global sports medicine is predicted to grow to around $35 billion by 2022, with the Asian market growing at a compound annual growth rate of nearly 7 percent.
Increased prevalence and awareness of neurological disorders in Asia present market growth opportunities for neurology companies.